Article ; Online: Bench to bedside: A role for erythropoietin in sepsis.
Critical care (London, England)
2010 Volume 14, Issue 4, Page(s) 227
Abstract: Sepsis is the systemic inflammatory response to infection and can result in multiple organ ... apoptotic, cytoprotective and immunomodulating actions, all of which could prove beneficial in sepsis ... been performed in patients with sepsis, good quality data exist from studies on anaemia ...
| Abstract | Sepsis is the systemic inflammatory response to infection and can result in multiple organ dysfunction syndrome with associated high mortality, morbidity and health costs. Erythropoietin is a well-established treatment for the anaemia of renal failure due to its anti-apoptotic effects on red blood cells and their precursors. The extra-haemopoietic actions of erythropoietin include vasopressor, anti-apoptotic, cytoprotective and immunomodulating actions, all of which could prove beneficial in sepsis. Attenuation of organ dysfunction has been shown in several animal models and its vasopressor effects have been well characterised in laboratory and clinical settings. Clinical trials of erythropoietin in single organ disorders have suggested promising cytoprotective effects, and while no randomised trials have been performed in patients with sepsis, good quality data exist from studies on anaemia in critically ill patients, giving useful information of its pharmacokinetics and potential for harm. An observational cohort study examining the microvascular effects of erythropoietin is underway and the evidence would support further phase II and III clinical trials examining this molecule as an adjunctive treatment in sepsis. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Animals ; Apoptosis/drug effects ; Apoptosis/physiology ; Blood Vessels/drug effects ; Blood Vessels/physiopathology ; Erythropoietin/adverse effects ; Erythropoietin/physiology ; Erythropoietin/therapeutic use ; Humans ; Sepsis/complications ; Sepsis/drug therapy ; Sepsis/physiopathology ; Systemic Inflammatory Response Syndrome/drug therapy ; Systemic Inflammatory Response Syndrome/physiopathology | |||||
| Chemical Substances | Erythropoietin (11096-26-7) | |||||
| Language | English | |||||
| Publishing date | 2010-08-06 | |||||
| Publishing country | England | |||||
| Document type | Journal Article ; Review | |||||
| ZDB-ID | 2041406-7 | |||||
| ISSN | 1466-609X ; 1364-8535 | |||||
| ISSN (online) | 1466-609X | |||||
| ISSN | 1364-8535 | |||||
| DOI | 10.1186/cc9049 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5517: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.